A DNA Nano-train Carrying a Predefined Drug Combination for Cancer Therapy
Qin Huang , Xin Liu , Pengge Zhang , Zhan Wu , Zilong Zhao
Chemical Research in Chinese Universities ›› 2022, Vol. 38 ›› Issue (4) : 928 -934.
A DNA Nano-train Carrying a Predefined Drug Combination for Cancer Therapy
Herein, we reported a tumor cell-targeting aptamer-nano-train to deliver paclitaxel(PTX) and combretastatin A4(CA4) at a predefined ratio to cancer cells based on DNA nanotechnology. Such a drug-carrying aptamer-nano-train(aptamer-NT-PTX/CA4) was prepared via self-assembly of two DNA hairpins, which were conjugated with PTX and CA4, respectively, induced by aptamer trigger. Our research revealed that the aptamer-NT-PTX/CA4 could specifically recognize CD71-positive cancer cells, but not CD71-negative healthy normal cells, and achieve synergistic therapeutic effect on cancer cells. The aptamer-nano-train-based strategy is simple and efficient, and provides a new platform for drug combination cancer therapy.
Targeted therapy / Drug combination cancer therapy / Aptamer / DNA nanostructure
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
/
| 〈 |
|
〉 |